Browsing: weightloss

Aug. 24 (Yonhap) — The number of attempts to illegally import weight-loss medications, such as Wegovy and Mounjaro, from abroad in the first half was more than triple those caught for the whole of 2025, customs data showed Monday

People who use prescription weight-loss medications showed higher rates of mental health problems such as feelings of depression and suicidal thoughts or behaviors than non-users. In particular, those who used weight-loss drugs and then regained weight were about 4.25 times more likely to have suicidal thoughts. Because this is a finding of statistical association rather…

Researchers at McMaster University have uncovered an unexpected role for a naturally occurring hormone already known for reducing appetite and supporting weight loss. The hormone appears to protect the liver from inflammation through a previously unknown signaling pathway, a finding that could point toward new approaches for treating advanced fatty liver disease

A personalized approach to obesity treatment may help breast cancer survivors improve their long-term health by identifying early which patients need more than behavioral lifestyle intervention alone

In the health care sector of the U.S. stock market, Eli Lilly (LLY) firmly holds the top spot with a market capitalization exceeding $1.1 trillion. However, compared with SpaceX (SPCX), the star company in space exploration, this figure still pales, as the latter is valued at as much as $1.8 trillion. Although Eli Lilly supports…

On August 10, Eli Lilly and Company (NYSE:LLY)’s weight-loss pill Foundayo won approval in the UK, becoming the first country in Europe to clear the drug for both weight management and type 2 diabetes. It’s only the second GLP-1 pill approved in Europe, arriving two months after Novo Nordisk A/S (NYSE:NVO)’s Wegovy pill got its…

FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it became available to patients in early January 2026. The response was immediate. Patients who had spent months dreading their weekly injections suddenly had a new question for their doctors, and doctors suddenly had a much harder question…

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>

[Sportschosun Kim Joon-seok] Comedian Yoo Min-sang said he started weight-loss injections after being shocked by a doctor’s comment during a health checkup

Eli Lilly and Company (NYSE:LLY) cleared a notable regulatory hurdle on August 10, when Britain’s drug regulator authorized the company’s oral GLP-1 drug orforglipron, becoming the first country in Europe to approve the pill. Shares of LLY increased more than 2% in response to the announcement, a modest but insightful reaction for a company whose…